-
1
-
-
0036291921
-
Pharmacokinetic-pharmacodynamic drug interactions with HMG-CoA reductase inhibitors
-
Williams D, Feely J. Pharmacokinetic-pharmacodynamic drug interactions with HMG-CoA reductase inhibitors. Clin Pharmacokinet 2002 41 : 343 70.
-
(2002)
Clin Pharmacokinet
, vol.41
, pp. 343-70
-
-
Williams, D.1
Feely, J.2
-
2
-
-
33644909875
-
Clinically relevant drug interactions with antiepileptic drugs
-
Perucca E. Clinically relevant drug interactions with antiepileptic drugs. Br J Clin Pharm 2005 61 : 246 55.
-
(2005)
Br J Clin Pharm
, vol.61
, pp. 246-55
-
-
Perucca, E.1
-
3
-
-
0037403686
-
Regulation of CYP3A4 expression in human hepatocytes by pharmaceuticals and natural products
-
Raucy JL. Regulation of CYP3A4 expression in human hepatocytes by pharmaceuticals and natural products. Drug Metab Dispos 2003 31 : 533 9.
-
(2003)
Drug Metab Dispos
, vol.31
, pp. 533-9
-
-
Raucy, J.L.1
-
4
-
-
0034964222
-
Pharmacokinetic and pharmacodynamic implications of P-glycoprotein modulation
-
Matheny CJ, Lamb WL, Brouwer KLR, Pollack GM. Pharmacokinetic and pharmacodynamic implications of P-glycoprotein modulation. Pharmacother 2001 21 : 778 96.
-
(2001)
Pharmacother
, vol.21
, pp. 778-96
-
-
Matheny, C.J.1
Lamb, W.L.2
Brouwer, K.L.R.3
Pollack, G.M.4
-
5
-
-
0034266349
-
HMG-CoA reductase inhibitors: Assessing differences in drug interactions and safety profiles
-
Beaird SL. HMG-CoA reductase inhibitors: assessing differences in drug interactions and safety profiles. J Am Pharm Assoc 2000 40 : 637 44.
-
(2000)
J Am Pharm Assoc
, vol.40
, pp. 637-44
-
-
Beaird, S.L.1
-
6
-
-
0031670167
-
Erythromycin and verapamil considerably increase serum simvastatin and simvastatin acid concentrations
-
Kantola T, Kivisto KT, Neuvonen PJ. Erythromycin and verapamil considerably increase serum simvastatin and simvastatin acid concentrations. Clin Pharmacol Ther 1998 64 : 177 82.
-
(1998)
Clin Pharmacol Ther
, vol.64
, pp. 177-82
-
-
Kantola, T.1
Kivisto, K.T.2
Neuvonen, P.J.3
-
7
-
-
37249091969
-
-
List no. 7D62-20, 30-59/R2. Abbott Park, IL: Abbott Laboratories, Diagnostics Division
-
Cholesterol Assay Aeroset® c8000™ Package Insert. List no. 7D62-20, 30-59/R2. Abbott Park, IL : Abbott Laboratories, Diagnostics Division January 2003.
-
(2003)
Cholesterol Assay Aeroset® c8000™ Package Insert.
-
-
-
8
-
-
0026547318
-
The effect of chronic phenytoin treatment on serum lipid profile in adult epileptic patients
-
Clandre EP, Porta BS, de la Caldeza DG. The effect of chronic phenytoin treatment on serum lipid profile in adult epileptic patients. Epilepsia 1992 33 : 154 7.
-
(1992)
Epilepsia
, vol.33
, pp. 154-7
-
-
Clandre, E.P.1
Porta, B.S.2
De La Caldeza, D.G.3
-
9
-
-
1942534724
-
The effect of long-term antiepileptic treatment on serum cholesterol (TC, HDL, LDL) and triglyceride levels in adult epileptic patients on monotherapy
-
Nikolaos T, Stylianos G, Chryssoula N, Irini P, Christos M, Dimitrios T, Konstantinos P, Antonis T. The effect of long-term antiepileptic treatment on serum cholesterol (TC, HDL, LDL) and triglyceride levels in adult epileptic patients on monotherapy. Med Sci Monit 2004 10 : MT50 52.
-
(2004)
Med Sci Monit
, vol.10
-
-
Nikolaos, T.1
Stylianos, G.2
Chryssoula, N.3
Irini, P.4
Christos, M.5
Dimitrios, T.6
Konstantinos, P.7
Antonis, T.8
-
10
-
-
0032937346
-
Efficacy of statin therapy: Possible effect of phenytoin
-
Murphy MJ, Dominiczak MH. Efficacy of statin therapy: possible effect of phenytoin. Postgrad Med J 1999 75 : 359 61.
-
(1999)
Postgrad Med J
, vol.75
, pp. 359-61
-
-
Murphy, M.J.1
Dominiczak, M.H.2
|